Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Venus Haoyue Medtech is a joint venture between Venus Medtech and Jilin Changchun Haoyue Halal Meat Co., Ltd. It focuses on the design, R&D, manufacturing, sales, and technical services of high-end cardiovascular implant devices and surgical soft tissue repair materials. Its main products include artificial biological heart valves for surgical implantation—such as aortic, pulmonary, mitral and tricuspid valves—and other biological patches. The company leverages advanced engineered dry valve technology to improve durability and safety of bioprosthetic valves. Clinical progress includes first-in-man trials for next-generation expandable dry-tissue valves.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Venus Haoyue Medtech.